(6S)-2-((3-CHLORO-4-FLUOROPHENYL)METHYL)-N,8-DIETHYL-1,2,6,7,8,9-HEXAHYDRO-10-HYDROXY-6-METHYL-1,9-DIOXOPYRAZINO(1',2':1,5)PYRROLO(2,3-D)PYRIDAZINE-4-CARBOXAMIDE
UNII 2V3GK8VNG6
Substance Identification & Data
This profile provides standardized clinical and technical data for (6s)-2-((3-chloro-4-fluorophenyl)methyl)-n,8-diethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-6-methyl-1,9-dioxopyrazino(1',2':1,5)pyrrolo(2,3-d)pyridazine-4-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2V3GK8VNG6.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 870005-19-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H23ClFN5O4 DNABWGUFTZTVKA-NSHDSACASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (6s)-2-((3-chloro-4-fluorophenyl)methyl)-n,8-diethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-6-methyl-1,9-dioxopyrazino(1',2':1,5)pyrrolo(2,3-d)pyridazine-4-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.